Ren et al. found in the in vitro experiment of pancreatic cancer that nsPEFs could inhibit the expression of cyclin by inhibiting the NF-κB signaling pathway, thereby inhibiting cell proliferation [21]. Here, NFKB1 is linked to pancreatic neoplasm.